J. Wolk is the Executive Vice President and Chief Financial Officer at Johnson & Johnson, a leading multinational corporation in the healthcare industry. In his role, Wolk oversees the company's global financial operations, including financial planning and analysis, accounting, tax, treasury, and investor relations. His strategic leadership has been instrumental in driving Johnson & Johnson's financial performance and growth. Prior to joining Johnson & Johnson in 2005, Wolk held various financial leadership positions at companies such as Bristol-Myers Squibb and KPMG. Throughout his career, he has demonstrated a strong ability to navigate complex financial landscapes and deliver results. At Johnson & Johnson, Wolk has played a key role in the company's acquisitions and divestitures, helping to shape its portfolio and drive shareholder value. His expertise in financial strategy and risk management has been crucial in maintaining the company's strong financial position and credit rating. Under Wolk's leadership, Johnson & Johnson has continued to invest in research and development, expand its global presence, and adapt to the evolving healthcare market. He has been recognized for his contributions to the company's success, receiving accolades such as being named one of the "Best CFOs in America" by Institutional Investor magazine. Wolk's commitment to integrity, transparency, and long-term value creation has made him a respected leader in the financial community and a valuable asset to Johnson & Johnson.